Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 35(10): 651-654, dic. 2017. ilus
Artigo em Inglês | IBECS | ID: ibc-169565

RESUMO

Objective: To characterize a methicillin-resistant Staphylococcus aureus (MRSA) isolate responsible for an aggressive infection (peridural and psoas abscess secondary to haematogenous septic arthritis) in a poultry farmer. Methods: Molecular characterization was performed, including spa- and multilocus sequence typing of the isolate, assessment of its resistance phenotype and detection of tetracycline resistance and of virulence and immune evasion cluster (IEC) genes were performed. Results: The MRSA isolate was tetracycline- and fluorquinolone-resistant, and was ascribed to CC398, spa-t1451. The isolate harboured tet(M) (distinctive of livestock-associated (LA) MRSA-CC398 clade) and IEC-type B system (characteristic of the methicillin-susceptible human lineage, but typically absent in LA-MRSA-CC398 strains), and lacked toxin-coding genes lukF/lukS-PV, tsst-1, eta and etb. Conclusion: IEC re-acquisition by LA-MRSA-CC398-LA strains is an unusual finding, but could constitute an emerging public health problem. It would represent an evolutionary step towards LA-MRSA-CC398's adaptation to human hosts, and might enhance its invasiveness and ability to be transmitted to humans (AU)


Objetivo: Caracterizar un aislado de Staphylococcus aureus resistente a meticilina (SARM), causante de una infección muy agresiva (absceso epidural y de psoas secundarios a artritis séptica hematógena) en un granjero avícola. Métodos: El aislado fue caracterizado molecularmente (spa- y multilocus sequence typing), y se estudió su fenotipo de resistencia y la presencia de genes de resistencia a tetraciclina, de virulencia y del sistema immune evasion cluster (IEC). Resultados: El aislado de SARM, resistente a tetraciclina y fluoroquinolonas, fue tipado como spa-t1451-CC398, albergaba el gen tet(M) (distintivo de SARM-CC398 asociado al ganado [AG]) y el sistema IEC-tipo B (característico de S. aureus meticilin-sensible-CC398 adscrito al clado humano, pero no de SARM-CC398-AG), carecía de lukF/lukS-PV, tsst-1, eta, y etb. Conclusión: La readquisición del sistema IEC por aislados SARM-CC398-AG es excepcional, pero constituiría un problema emergente de salud pública. Representaría un paso evolutivo en la readaptación de SARM-CC398-AG al hombre, pudiendo incrementar su invasividad y transmisibilidad a humanos (AU)


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Evasão da Resposta Imune/genética , Staphylococcus aureus Resistente à Meticilina/isolamento & purificação , Abscesso Epidural/diagnóstico , Abscesso Epidural/microbiologia , Abscesso do Psoas/diagnóstico , Abscesso do Psoas/microbiologia , Abscesso Epidural/genética , Abscesso Epidural/imunologia , Artrite Infecciosa/complicações , Artrite Infecciosa/diagnóstico , Artrite Infecciosa/microbiologia , Combinação Amoxicilina e Clavulanato de Potássio/uso terapêutico , Técnicas Microbiológicas/métodos
2.
Blood Cells Mol Dis ; 57: 8-12, 2016 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-26852649

RESUMO

BACKGROUND: In congenital Factor (F) VII deficiency bleeding phenotype and intrinsic FVII activity levels don't always correlate. Patients with FVII activity levels <30% appear to have a higher bleeding propensity, but bleeding can also occur at higher FVII activity levels. Reasons for bleeding at higher FVII activity levels are unknown, and it remains challenging to manage such patients clinically. CASE: A 19year old male with spontaneous intracranial hemorrhage and FVII activity levels of 44%, requiring emergent surgical intervention and a strategy for FVII replacement. Genotyping showed the rare heterozygous FVII 9729del4 mutation. Bleed evacuation was complicated by epidural abscess requiring craniectomy, bone graft procedures, and prolonged administration of recombinant human (rh) activated FVII (FVIIa). The patient recovered without neurological deficits, and remains on prophylactic low dose treatment with rhFVIIa in relation to risky athletic activities. CONCLUSION: For clinicians, it is important to recognize that effects of rhFVIIa within these pathways are independent of its contribution to blood clot formation and cannot be assessed by clotting assays. Reduced FVII levels should therefore not be dismissed, as even a mild reduction may result in spontaneous bleeding. Treatment of mild FVII deficiency requires a careful case-by-case approach, based on the clinical scenario.


Assuntos
Sequência de Bases , Hemorragia Cerebral/genética , Abscesso Epidural/genética , Deficiência do Fator VII/genética , Fator VII/genética , Deleção de Sequência , Transplante Ósseo , Hemorragia Cerebral/complicações , Hemorragia Cerebral/patologia , Hemorragia Cerebral/terapia , Análise Mutacional de DNA , Craniectomia Descompressiva , Abscesso Epidural/complicações , Abscesso Epidural/patologia , Abscesso Epidural/terapia , Deficiência do Fator VII/complicações , Deficiência do Fator VII/patologia , Deficiência do Fator VII/terapia , Fator VIIa/uso terapêutico , Expressão Gênica , Heterozigoto , Humanos , Masculino , Dados de Sequência Molecular , Proteínas Recombinantes/uso terapêutico , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...